2024 Q2 Form 10-Q Financial Statement

#000162828024020033 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.760B $1.789B
YoY Change 5.08% 7.44%
Cost Of Revenue $1.498B $1.495B
YoY Change 5.23% 5.34%
Gross Profit $261.6M $294.2M
YoY Change 4.26% 19.51%
Gross Profit Margin 14.87% 16.45%
Selling, General & Admin $49.88M $48.45M
YoY Change 17.34% 14.59%
% of Gross Profit 19.07% 16.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $53.94M $54.07M
YoY Change 8.01% 3.14%
% of Gross Profit 20.62% 18.38%
Operating Expenses $103.8M $100.2M
YoY Change 13.19% 5.84%
Operating Profit $157.8M $194.0M
YoY Change -0.88% 28.07%
Interest Expense -$30.79M $50.76M
YoY Change -162.84% 4.51%
% of Operating Profit -19.51% 26.17%
Other Income/Expense, Net
YoY Change
Pretax Income $127.0M $153.6M
YoY Change 5.22% 37.85%
Income Tax $32.24M $36.46M
% Of Pretax Income 25.39% 23.73%
Net Earnings $77.56M $96.90M
YoY Change -0.86% 36.85%
Net Earnings / Revenue 4.41% 5.42%
Basic Earnings Per Share $0.60 $0.75
Diluted Earnings Per Share $0.60 $0.75
COMMON SHARES
Basic Shares Outstanding 130.0M shares 128.4M shares
Diluted Shares Outstanding 123.9M shares 123.9M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $111.2M $92.62M
YoY Change 9.88% 10.65%
Cash & Equivalents $111.2M $92.62M
Short-Term Investments
Other Short-Term Assets $145.1M $161.2M
YoY Change 4.98% 12.18%
Inventory
Prepaid Expenses
Receivables $1.078B $1.135B
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.365B $1.440B
YoY Change 4.65% 9.64%
LONG-TERM ASSETS
Property, Plant & Equipment $1.031B $1.025B
YoY Change 2.6% 3.78%
Goodwill $3.525B $3.517B
YoY Change 1.13% 0.93%
Intangibles $316.9M $324.1M
YoY Change -8.6% -6.49%
Long-Term Investments
YoY Change
Other Assets $384.4M $375.4M
YoY Change 7.09% 6.04%
Total Long-Term Assets $6.510B $6.418B
YoY Change 1.76% 0.5%
TOTAL ASSETS
Total Short-Term Assets $1.365B $1.440B
Total Long-Term Assets $6.510B $6.418B
Total Assets $7.875B $7.858B
YoY Change 2.25% 2.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $160.1M $163.6M
YoY Change -14.27% -6.06%
Accrued Expenses $247.9M $245.6M
YoY Change -72.59% -71.2%
Deferred Revenue
YoY Change
Short-Term Debt $23.63M $28.53M
YoY Change -24.99% -8.65%
Long-Term Debt Due $46.43M $60.18M
YoY Change -18.83% -47.16%
Total Short-Term Liabilities $1.257B $1.184B
YoY Change 5.79% -0.11%
LONG-TERM LIABILITIES
Long-Term Debt $3.594B $3.759B
YoY Change -2.75% -0.22%
Other Long-Term Liabilities $98.68M $100.2M
YoY Change -6.13% -6.07%
Total Long-Term Liabilities $98.68M $100.2M
YoY Change -6.13% -6.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.257B $1.184B
Total Long-Term Liabilities $98.68M $100.2M
Total Liabilities $6.139B $6.192B
YoY Change -0.44% -0.87%
SHAREHOLDERS EQUITY
Retained Earnings $891.4M $830.8M
YoY Change 27.9% 30.74%
Common Stock $519.4M $505.5M
YoY Change 9.56% 9.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.417B $1.367B
YoY Change
Total Liabilities & Shareholders Equity $7.875B $7.858B
YoY Change 2.25% 2.06%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $77.56M $96.90M
YoY Change -0.86% 36.85%
Depreciation, Depletion And Amortization $53.94M $54.07M
YoY Change 8.01% 3.14%
Cash From Operating Activities $278.2M -$66.69M
YoY Change 18.44% -229.64%
INVESTING ACTIVITIES
Capital Expenditures $55.55M $52.52M
YoY Change -6.66% -10.81%
Acquisitions $5.405M
YoY Change 1261.46%
Other Investing Activities $1.480M -$5.140M
YoY Change -120.28% -49.49%
Cash From Investing Activities -$54.07M -$57.66M
YoY Change -19.08% -16.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -205.5M $133.0M
YoY Change 36.52% 3788.86%
NET CHANGE
Cash From Operating Activities 278.2M -$66.69M
Cash From Investing Activities -54.07M -$57.66M
Cash From Financing Activities -205.5M $133.0M
Net Change In Cash 18.54M $8.614M
YoY Change 6.16% -160.65%
FREE CASH FLOW
Cash From Operating Activities $278.2M -$66.69M
Capital Expenditures $55.55M $52.52M
Free Cash Flow $222.6M -$119.2M
YoY Change 26.97% 1501.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
128369492 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128369492 shares
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1418819000 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1494610000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42279000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48447000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
52425000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54069000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1356564000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
1513523000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
1597126000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2284000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
151457000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
193967000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8556000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10421000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
48571000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
50763000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
111442000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
153625000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26185000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36458000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
85257000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
117167000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
14452000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
20270000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
70805000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
96897000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2023Q1 us-gaap Profit Loss
ProfitLoss
85257000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
117167000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-2696000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
4370000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
13252000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
16347000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-5175000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-3782000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-15948000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-11977000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
69309000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
105190000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
14452000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
20270000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
54857000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
84920000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1547718000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-17845000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
16045000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2024Q1 sem Restricted Stock Award Forfeitures Par Value Of Shares Forfeited Including Effects Of Dividends Reclassified To Retained Earnings
RestrictedStockAwardForfeituresParValueOfSharesForfeitedIncludingEffectsOfDividendsReclassifiedToRetainedEarnings
-14000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11596000 usd
CY2024Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
4002000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10506000 usd
CY2024Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-1901000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11977000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1637643000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-12811000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
15897000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10003000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
3877000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
6069000 usd
CY2023Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-436000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15948000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1418441000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
85257000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
117167000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2566000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
12374000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
52425000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54069000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
429000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
854000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8556000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10421000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
7000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-44000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10181000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11610000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
565000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
750000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2601000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6891000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55397000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
195308000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
11742000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
9611000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3659000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2363000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4564000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5718000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-20775000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-37971000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
51440000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-66689000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
397000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5405000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
58885000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
52517000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
9800000 usd
CY2024Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
20000 usd
CY2024Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
265000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69062000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57657000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
225000000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
495000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
210000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
265000000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
79085000 usd
CY2023Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
21448000 usd
CY2024Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
17728000 usd
CY2023Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
11170000 usd
CY2024Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
9061000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15897000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
16045000 usd
CY2023Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-724000 usd
CY2024Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-1740000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
2731000 usd
CY2024Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
4002000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
7969000 usd
CY2024Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
12839000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3419000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
132960000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14203000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8614000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97906000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84006000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83703000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92620000 usd
CY2023Q1 us-gaap Derivative Cash Received On Hedge
DerivativeCashReceivedOnHedge
17828000 usd
CY2024Q1 us-gaap Derivative Cash Received On Hedge
DerivativeCashReceivedOnHedge
22515000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
84531000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
88834000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
336000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
604000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.</span></div>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Credit Risk Concentrations<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash balances and accounts receivable. The Company’s excess cash is held with large financial institutions. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company’s facilities and are insured under third-party payor agreements.</span></div>Because of the diversity in the Company’s non-governmental third-party payor base, as well as their geographic dispersion, accounts receivable due from the Medicare program represent the Company’s only significant concentration of credit risk.
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
34043000 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
26297000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1641000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
2425000 usd
CY2023Q1 sem Noncontrolling Interest Distributionsto Redeemable Noncontrolling Interests
NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests
1900000 usd
CY2024Q1 sem Noncontrolling Interest Distributionsto Redeemable Noncontrolling Interests
NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests
2333000 usd
CY2023Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-436000 usd
CY2024Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-1901000 usd
CY2023Q1 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
179000 usd
CY2024Q1 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
0 usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
34399000 usd
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
28290000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
354000 usd
CY2023Q1 sem Finance Lease Interest Expense Unrelated Parties
FinanceLeaseInterestExpenseUnrelatedParties
320000 usd
CY2023Q1 sem Operating Lease Cost Unrelated Parties
OperatingLeaseCostUnrelatedParties
76632000 usd
CY2023Q1 sem Operating Lease Cost Related Parties
OperatingLeaseCostRelatedParties
1834000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
78466000 usd
CY2024Q1 sem Operating Lease Cost Unrelated Parties
OperatingLeaseCostUnrelatedParties
79055000 usd
CY2024Q1 sem Operating Lease Cost Related Parties
OperatingLeaseCostRelatedParties
1834000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
80889000 usd
CY2023Q1 sem Finance Lease Right Of Use Asset Amortization Unrelated Parties
FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties
394000 usd
CY2023Q1 sem Finance Lease Right Of Use Asset Amortization Related Parties
FinanceLeaseRightOfUseAssetAmortizationRelatedParties
0 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
394000 usd
CY2024Q1 sem Finance Lease Right Of Use Asset Amortization Unrelated Parties
FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties
354000 usd
CY2024Q1 sem Finance Lease Right Of Use Asset Amortization Related Parties
FinanceLeaseRightOfUseAssetAmortizationRelatedParties
0 usd
CY2023Q1 sem Finance Lease Interest Expense Related Parties
FinanceLeaseInterestExpenseRelatedParties
0 usd
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
320000 usd
CY2024Q1 sem Finance Lease Interest Expense Unrelated Parties
FinanceLeaseInterestExpenseUnrelatedParties
304000 usd
CY2024Q1 sem Finance Lease Interest Expense Related Parties
FinanceLeaseInterestExpenseRelatedParties
0 usd
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
304000 usd
CY2023Q1 sem Variable Lease Cost Unrelated Parties
VariableLeaseCostUnrelatedParties
15761000 usd
CY2023Q1 sem Variable Lease Cost Related Parties
VariableLeaseCostRelatedParties
84000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
15845000 usd
CY2024Q1 sem Variable Lease Cost Unrelated Parties
VariableLeaseCostUnrelatedParties
17076000 usd
CY2024Q1 sem Variable Lease Cost Related Parties
VariableLeaseCostRelatedParties
0 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
17076000 usd
CY2023Q1 sem Sublease Income Unrelated Parties
SubleaseIncomeUnrelatedParties
1678000 usd
CY2023Q1 sem Sublease Income Related Parties
SubleaseIncomeRelatedParties
0 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
1678000 usd
CY2024Q1 sem Sublease Income Unrelated Parties
SubleaseIncomeUnrelatedParties
1760000 usd
CY2024Q1 sem Sublease Income Related Parties
SubleaseIncomeRelatedParties
0 usd
CY2024Q1 us-gaap Sublease Income
SubleaseIncome
1760000 usd
CY2023Q1 sem Lease Cost Unrelated Parties
LeaseCostUnrelatedParties
91429000 usd
CY2023Q1 sem Lease Cost Related Parties
LeaseCostRelatedParties
1918000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
93347000 usd
CY2024Q1 sem Lease Cost Unrelated Parties
LeaseCostUnrelatedParties
95029000 usd
CY2024Q1 sem Lease Cost Related Parties
LeaseCostRelatedParties
1834000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
96863000 usd
CY2024Q1 sem Long Term Debt Gross And Finance Lease Obligation
LongTermDebtGrossAndFinanceLeaseObligation
3826067000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-2953000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
10205000 usd
CY2024Q1 sem Long Term Debt And Finance Lease Obligation
LongTermDebtAndFinanceLeaseObligation
3818815000 usd
CY2024Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
3826244000 usd
CY2024Q1 sem Long Term Debt And Finance Lease Obligation Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear
58155000 usd
CY2024Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3151000 usd
CY2024Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Two
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo
1227461000 usd
CY2024Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Three
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree
2525341000 usd
CY2024Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Four
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour
1620000 usd
CY2024Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal After Year Four
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour
10339000 usd
CY2024Q1 sem Long Term Debt Gross And Finance Lease Obligation
LongTermDebtGrossAndFinanceLeaseObligation
3826067000 usd
CY2023Q4 sem Long Term Debt Gross And Finance Lease Obligation
LongTermDebtGrossAndFinanceLeaseObligation
3665740000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-3493000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
11229000 usd
CY2023Q4 sem Long Term Debt And Finance Lease Obligation
LongTermDebtAndFinanceLeaseObligation
3658004000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
3667340000 usd
CY2023Q4 sem Accrued Salaries Accrued Bonuses And Accrued Payroll Taxes Current
AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent
238768000 usd
CY2024Q1 sem Accrued Salaries Accrued Bonuses And Accrued Payroll Taxes Current
AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent
184801000 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
157748000 usd
CY2024Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
164113000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
32472000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
14438000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
297663000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
292587000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1499000 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
30552000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
728150000 usd
CY2024Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
686491000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1664980000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1788809000 usd
CY2023Q1 sem Adjusted Ebitda
AdjustedEbitda
214063000 usd
CY2024Q1 sem Adjusted Ebitda
AdjustedEbitda
261917000 usd
CY2023Q1 us-gaap Assets
Assets
7699736000 usd
CY2024Q1 us-gaap Assets
Assets
7858263000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
58885000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
52517000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
151457000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8556000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
48571000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
111442000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
193967000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10421000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
50763000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
153625000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1664980000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1788809000 usd
CY2024Q1 us-gaap Dividends And Interest Paid
DividendsAndInterestPaid
0 usd
CY2023Q1 us-gaap Dividends And Interest Paid
DividendsAndInterestPaid
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
85257000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
117167000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
14452000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
20270000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
70805000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
96897000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
2573000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
2573000 usd
CY2024Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
3398000 usd
CY2024Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
3398000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
68232000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
68232000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
93499000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
93499000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
68232000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
68232000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122553000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122553000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
93499000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
93499000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123859000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
123859000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
2573000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
2573000 usd
CY2023Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
4622000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2024Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
3398000 usd
CY2024Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
3398000 usd
CY2024Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
4501000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
70805000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
96897000 usd
CY2024Q1 sem Loss Contingency Number Of Patients
LossContingencyNumberOfPatients
4000000 patient
CY2024Q1 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
6 class_action_lawsuit
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-020033-index-headers.html Edgar Link pending
0001628280-24-020033-index.html Edgar Link pending
0001628280-24-020033.txt Edgar Link pending
0001628280-24-020033-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sem-20240331.htm Edgar Link pending
sem-20240331.xsd Edgar Link pending
sem-331202410qxex311.htm Edgar Link pending
sem-331202410qxex312.htm Edgar Link pending
sem-331202410qxex321.htm Edgar Link pending
Show.js Edgar Link pending
sem-20240331_lab.xml Edgar Link unprocessable
sem-20240331_pre.xml Edgar Link unprocessable
sem-20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
sem-20240331_cal.xml Edgar Link unprocessable
sem-20240331_def.xml Edgar Link unprocessable